RT Journal Article SR Electronic T1 Health Impact Assessment of PM2.5 attributable mortality from the September 2020 Washington State Wildfire Smoke Episode JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.19.20197921 DO 10.1101/2020.09.19.20197921 A1 Liu, Yisi A1 Austin, Elena A1 Xiang, Jianbang A1 Gould, Tim A1 Larson, Tim A1 Seto, Edmund YR 2020 UL http://medrxiv.org/content/early/2020/10/20/2020.09.19.20197921.abstract AB Major wildfires that started in the summer of 2020 along the west coast of the U.S. have made PM2.5 concentrations in cities in this region rank among the highest in the world. Regions of Washington were impacted by active wildfires in the state, and by aged wood smoke transported from fires in Oregon and California. This study aims to assess the population health impact of increased PM2.5 concentrations attributable to the wildfire. Average daily PM2.5 concentrations for each county before and during the 2020 Washington wildfire episode were obtained from the Washington Department of Ecology. Utilizing previously established associations of short-term mortality for PM2.5, we estimated excess mortality for Washington attributable to the increased PM2.5 levels. On average, PM2.5 concentrations increased 91.7 μg/m3 during the wildfire episode. Each week of wildfire smoke exposures was estimated to result in 87.6 (95% CI: 70.9, 103.1) cases of increased all-cause mortality, 19.1 (95% CI: 10.0, 28.2) increased cardiovascular disease deaths, and 9.4 (95% CI: 5.1, 13.5) increased respiratory disease deaths. Because wildfire smoke episodes are likely to continue impacting the Pacific Northwest in future years, continued preparedness and mitigations to reduce exposures to wildfire smoke are necessary to avoid this excess health burden.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is supported in part by NIH grant 5P30 ES007033-23 and the China Scholarship Council for the Fellowship funding to YL.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was not required for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in Washington Department of Ecology (https://enviwa.ecology.wa.gov/Report/Hr24PM25SummaryNew), and the U.S. Census Bureau (https://www.census.gov/data/datasets/time-series/demo/popest/2010s-counties-total.html). https://enviwa.ecology.wa.gov/Report/Hr24PM25SummaryNew